Chairman Waxman asks CDC Director Gerberding and HRSA Director Duke to conduct additional analysis to answer questions about the impact of the expanded testing program on the demand for care and treatment of HIV. Chairman Waxman also asks Dr. Gerberding to explain CDC’s position on the role of prevention counseling provided in conjunction with testing.